PT - JOURNAL ARTICLE AU - COVID-19 Basque Inter-institutional Group (coBIG) AU - coordinators and participants: AU - Guruceaga, Xabier AU - Sierra, Amanda AU - Marino, Daniel AU - Santin, Izortze AU - Nieto-Garai, Jon Ander AU - Bilbao, Jose Ramón AU - Lorizate, Maier AU - Aspichueta, Patricia AU - Gaminde-Blasco, Adhara AU - Bozal-Leorri, Adrian AU - Marín-Peña, Agustín AU - Castellanos-Rubio, Ainara AU - Iglesias-Ara, Ainhoa AU - Rementeria, Aitor AU - Bernal-Chico, Ana AU - Ramirez-Garcia, Andoni AU - Olazagoitia-Garmendia, Ane AU - Benito-Vicente, Asier AU - Martín, César AU - Castellanos, Eider Bilbao AU - Rueda-Alaña, Eneritz AU - Cavaliere, Fabio AU - de Nanclares, Guiomar Perez AU - Aurrekoetxea, Igor AU - Garcia-Santisteban, Iraia AU - Bernales, Irantzu AU - Gonzalez-Moro, Itziar AU - Tønnesen, Jan AU - Baleriola, Jimena AU - Vallejo-Rodríguez, Jon AU - Aparicio-Fernandez, Leire AU - Martin-Souto, Leire AU - Mendoza, Luis Manuel AU - Areitio, Maialen AU - Sebastian-delaCruz, Maialen AU - Ortiz-Zarragoitia, Maren AU - Serrano-Regal, Mari Paz AU - Basaras, Miren AU - Fernandez-Jimenez, Nora AU - Pampliega, Olatz AU - Alegre, Santos Alonso AU - Marcos, Susi AU - Fuertes-Mendizabal, Teresa AU - Galicia-Garcia, Unai AU - Perez-Cuesta, Uxue AU - Torrano, Verónica AU - Sierra-Torre, Virginia AU - Buqué, Xabier AU - Mayor, Ugo TI - Fast SARS-CoV-2 detection protocol based on RNA precipitation and RT-qPCR in nasopharyngeal swab samples AID - 10.1101/2020.04.26.20081307 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.26.20081307 4099 - http://medrxiv.org/content/early/2020/05/01/2020.04.26.20081307.short 4100 - http://medrxiv.org/content/early/2020/05/01/2020.04.26.20081307.full AB - The SARS-CoV-2 pandemic has evolved far more aggressively in countries lacking a robust testing strategy to identify infected individuals. Given the global demand for fast and reliable diagnosis to determine the carrier individuals, a stock-out scenario for a number of essential reagents/kits used along the diagnostic process has been foreseen by many organizations. Having identified the RNA extraction step as one of the key bottlenecks, we tested several alternatives that avoid the use of commercial kits for this step. The analysis showed that 2-propanol precipitation of the viral RNA, followed by one-step RT-qPCR results in a sensitivity and specificity comparable to that provided currently by automatized systems such as the COBAS 6800 system. Therefore, this simple protocol allows SARS-CoV-2 testing independently of commercial kit providers in a time and cost-effective manner. It can be readily implemented in research and/or diagnostic laboratories worldwide, provided that patient confidentiality and researcher safety are ensured. Scaling up the testing capabilities of hospitals and research facilities will identify larger numbers of infected individuals to paint a clear picture of the COVID-19 prevalence, a pre-requisite for informed policy decision making.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by funding from the UPV/EHU (Acción Especial “Desarrollo e implementación del test de diagnóstico para COVID-19”). None of the authors received payments or services from a third party for any aspect of the submitted work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data will be available upon request. The protocol is open and can be found at: https://www.ehu.eus/es/web/umayor/covid-19-protocol-en